Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-06-25
DOI
10.3389/fphar.2014.00146
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Many Substrates of Presenilin/γ-Secretase
- (2018) Annakaisa Haapasalo et al. JOURNAL OF ALZHEIMERS DISEASE
- A New Mechanism for Amyloid-β Induction of iNOS: Vitamin D-VDR Pathway Disruption
- (2018) Erdinç Dursun et al. JOURNAL OF ALZHEIMERS DISEASE
- Uridine Prodrug Improves Memory in Tg2576 and TAPP Mice and Reduces Pathological Factors associated with Alzheimer's Disease in Related Models
- (2018) Joel A. Saydoff et al. JOURNAL OF ALZHEIMERS DISEASE
- Maternal Breastfeeding History and Alzheimer's Disease Risk
- (2018) Molly Fox et al. JOURNAL OF ALZHEIMERS DISEASE
- Tetrahydrohyperforin Induces Mitochondrial Dynamics and Prevents Mitochondrial Ca2+ Overload after Aβ and Aβ-AChE Complex Challenge in Rat Hippocampal Neurons
- (2018) Juan M. Zolezzi et al. JOURNAL OF ALZHEIMERS DISEASE
- Motor Effects of REAC in Advanced Alzheimer's Disease: Results From a Pilot Trial
- (2018) Javier Olazarán et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Intervention with an Estrogen Receptor β-Selective Phytoestrogenic Formulation Prolongs Survival, Improves Spatial Recognition Memory, and Slows Progression of Amyloid Pathology in a Female Mouse Model of Alzheimer's Disease
- (2018) Liqin Zhao et al. JOURNAL OF ALZHEIMERS DISEASE
- β-Adrenergic Receptors and G Protein-Coupled Receptor Kinase-2 in Alzheimer's Disease: A New Paradigm for Prognosis and Therapy?
- (2018) Grazia Daniela Femminella et al. JOURNAL OF ALZHEIMERS DISEASE
- Nmnat2 Attenuates Tau Phosphorylation Through Activation of PP2A
- (2018) Xiang-Shu Cheng et al. JOURNAL OF ALZHEIMERS DISEASE
- Angiotensin Converting Enzyme Inhibitors and the Reduced Risk of Alzheimer's Disease in the Absence of Apolipoprotein E4 Allele
- (2018) Wei Qiao Qiu et al. JOURNAL OF ALZHEIMERS DISEASE
- Improved Spatial Learning Strategy and Memory in Aged Alzheimer AβPPswe/PS1dE9 Mice on a Multi-Nutrient Diet
- (2018) Maximilian Wiesmann et al. JOURNAL OF ALZHEIMERS DISEASE
- Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit
- (2018) Szilvia Veszelka et al. JOURNAL OF ALZHEIMERS DISEASE
- Heterogeneity in Red Wine Polyphenolic Contents Differentially Influences Alzheimer's Disease-type Neuropathology and Cognitive Deterioration
- (2017) Lap Ho et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
- (2017) Marjo H. Eskelinen et al. JOURNAL OF ALZHEIMERS DISEASE
- Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
- (2014) Sergio T. Ferreira et al. Alzheimers & Dementia
- Future directions in Alzheimer's disease from risk factors to prevention
- (2014) Bushra Imtiaz et al. BIOCHEMICAL PHARMACOLOGY
- New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
- (2014) Miguel Medina et al. BIOCHEMICAL PHARMACOLOGY
- Brain metabolic dysfunction at the core of Alzheimer's disease
- (2014) Suzanne M. de la Monte et al. BIOCHEMICAL PHARMACOLOGY
- From the Multifactorial Nature of Alzheimer`s Disease to Multitarget Therapy: The Contribution of the Translational Approach
- (2014) Laura Calzà et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Type 2 Diabetes and Cognitive Impairment
- (2014) John P. Ryan et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Pathways to Alzheimer's disease
- (2014) J. Hardy et al. JOURNAL OF INTERNAL MEDICINE
- Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors
- (2014) Mitsuru Shinohara et al. Frontiers in Aging Neuroscience
- Rationale and clinical data supporting nutritional intervention in Alzheimer’s disease
- (2014) S. Engelborghs et al. ACTA CLINICA BELGICA
- A fast growing spectrum of biological functions of γ-secretase in development and disease
- (2013) Nathalie Jurisch-Yaksi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
- (2013) Bruce H. Morimoto et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- β2Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models
- (2013) Dayong Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vascular Aspects of Cognitive Impairment and Dementia
- (2013) Maximilian Wiesmann et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?
- (2013) Michela Rosini et al. JOURNAL OF MEDICINAL CHEMISTRY
- From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein
- (2013) Jean-Noël Octave et al. JOURNAL OF NEUROCHEMISTRY
- Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
- (2013) Donna M Wilcock et al. Journal of Neuroinflammation
- The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment
- (2013) Maria Koutroumani et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat!
- (2013) Ashraf Virmani et al. MOLECULAR NEUROBIOLOGY
- Molecular links between Alzheimer’s disease and diabetes mellitus
- (2013) Y. Yang et al. NEUROSCIENCE
- The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
- (2013) Anna Sandebring et al. PLoS One
- Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
- (2012) Ana García-Osta et al. ACS Chemical Neuroscience
- Dementia Resulting From Traumatic Brain Injury
- (2012) Sharon Shively et al. ARCHIVES OF NEUROLOGY
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
- (2012) Miguel Medina et al. CURRENT PHARMACEUTICAL DESIGN
- Pancortins interact with amyloid precursor protein and modulate cortical cell migration
- (2012) H. C. Rice et al. DEVELOPMENT
- Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid Depression
- (2012) Amir A. Sepehry et al. DRUGS & AGING
- Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease
- (2012) Lap Ho et al. FASEB JOURNAL
- Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
- (2012) Francesco Panza et al. Immunotherapy
- Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models
- (2012) E. M. Sontag et al. JOURNAL OF NEUROSCIENCE
- β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease
- (2012) Amantha Thathiah et al. NATURE MEDICINE
- Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
- (2012) Loukia Katsouri et al. NEUROBIOLOGY OF AGING
- Association of Coffee Drinking with Total and Cause-Specific Mortality
- (2012) Neal D. Freedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pleiotropic Protective Effects of Phytochemicals in Alzheimer's Disease
- (2012) Sergio Davinelli et al. Oxidative Medicine and Cellular Longevity
- Cellular mechanisms of γ-secretase substrate selection, processing and toxicity
- (2012) Gael Barthet et al. PROGRESS IN NEUROBIOLOGY
- A Clinical Perspective: Anti Taus Treatment in Alzheimers Disease
- (2011) P. Fuentes et al. Current Alzheimer Research
- Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
- (2011) M. Cuadrado-Tejedor et al. CURRENT MEDICINAL CHEMISTRY
- Amyloid β Peptide-(1–42) Induces Internalization and Degradation of β2Adrenergic Receptors in Prefrontal Cortical Neurons
- (2011) Dayong Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The physiology of the β-amyloid precursor protein intracellular domain AICD
- (2011) Raphaëlle Pardossi-Piquard et al. JOURNAL OF NEUROCHEMISTRY
- Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’
- (2011) Rudy J Castellani et al. JOURNAL OF PATHOLOGY
- Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit
- (2011) Manuel T Gersbacher et al. Molecular Neurodegeneration
- Functions of the APP gene family in the nervous system: insights from mouse models
- (2011) Dorothee Aydin et al. EXPERIMENTAL BRAIN RESEARCH
- Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
- (2010) David X. Medina et al. BRAIN PATHOLOGY
- Blocking β2-adrenergic receptor attenuates acute stress-induced amyloid β peptides production
- (2010) Nan-Nan Yu et al. BRAIN RESEARCH
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
- (2010) James A. Duce et al. CELL
- Development of an Efficient Therapeutic Agent for Alzheimer's Disease: Design and Synthesis of Dual Inhibitors of Acetylcholinesterase and Serotonin Transporter
- (2010) Narihiro Toda et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Is Elevated Norepinephrine an Etiological Factor in Some Cases of Alzheimers Disease?
- (2010) P. J. Fitzgerald Current Alzheimer Research
- From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™
- (2010) I. Okun et al. Current Alzheimer Research
- Neurobiological Effects of Hyperforin and its Potential in Alzheimers Disease Therapy
- (2010) T. Griffith et al. CURRENT MEDICINAL CHEMISTRY
- Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer’s disease model
- (2010) Niall M. Corcoran et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- Decaffeinated Coffee and Nicotine-Free Tobacco Provide Neuroprotection in Drosophila Models of Parkinson's Disease through an NRF2-Dependent Mechanism
- (2010) K. Trinh et al. JOURNAL OF NEUROSCIENCE
- Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
- (2010) Frauke van Bebber et al. NEUROBIOLOGY OF DISEASE
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
- (2010) Stephanie J. Soscia et al. PLoS One
- Pathological role of hypoxia in Alzheimer's disease
- (2009) Xin Zhang et al. EXPERIMENTAL NEUROLOGY
- Signaling effect of amyloid-β42 on the processing of AβPP
- (2009) Massimo Tabaton et al. EXPERIMENTAL NEUROLOGY
- Apolipoprotein E ɛ4 magnifies lifestyle risks for dementia: a population-based study
- (2008) Miia Kivipelto et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease
- (2008) Y. Matsuoka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Memory loss caused by β-amyloid protein is rescued by a β3-adrenoceptor agonist
- (2008) Marie E. Gibbs et al. NEUROBIOLOGY OF AGING
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started